Antibacterial fatty acids: An update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents

Abstract

The antibacterial activity of fatty acids (FA) is well known in the literature and represents a promising option for developing the next-generation of antibacterial agents to treat a broad spectrum of bacterial infections. FA are highly involved in living organisms' defense system against numerous pathogens, including multidrug-resistant bacteria. When combined with other antibacterial agents, the remarkable ability of FA to enhance their bactericidal properties is a critical feature that is not commonly observed in other naturally-occurring compounds. More reviews focusing on FA antibacterial activity, traditional and non-traditional mechanisms and biomedical applications are needed. This review is intended to update the reader on the antibacterial properties of recent FA and how their chemical structures influence their antibacterial activity. This review also aims to better understand both traditional and non-traditional mechanisms involved in these recently explored FA antibacterial activities.

References 73

1. 1.

   Desbois A, Smith V. Antibacterial free fatty acids: Activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 2010;85(6):1629–42.

   Not in our library10.1007/s00253-009-2355-3

2. 2.

   Kabara J, Swieczkowski D, Conley A, Truant J. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 1972;2(1):23–8.

   Not in our library10.1128/aac.2.1.23

3. 3.

   Venkata Mohan S, Rohit M, Chiranjeevi P, Chandra R, Navaneeth B. Heterotrophic microalgae cultivation to synergize biodiesel production with waste remediation: Progress and perspectives. Bioresour Technol 2015;184:169–78.

   Not in our library10.1016/j.biortech.2014.10.056

4. 4.

   Desbois A Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries. Recent Pat Antiinfect Drug Discov 2012;7(2):111–22.

   Not in our library10.2174/157489112801619728

5. 5.

   Centers for Disease Control and Prevention (CDC). Antibiotic/Antimicrobial Resistance. https://www.cdc.gov/drugresistance/;.. 2020. accessed 21 January 2021.

   Not in our library

6. 6.

   Yin H, Li G, Chen X, Wang W, Wong P, Zhao H, Accelerated evolution of bacterial antibiotic resistance through early emerged stress responses driven by photocatalytic oxidation. Appl Catal B 2020;269:118829.

   Not in our library

7. 7.
   Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications · 2018

   No notice
8. 8.

   Kumar P, Lee J, Beyenal H, Lee J. Fatty acids as antibiofilm and antivirulence agents. Trends Microbiol 2020;28(9):753–68.

   Not in our library10.1016/j.tim.2020.03.014

9. 9.

   Sanabria-Ríos D, Morales-Guzmán C, Mooney J, Medina S, Pereles-De–León T, Rivera-Román A, Antibacterial activity of hexadecynoic acid isomers toward clinical isolates of multidrug-resistant Staphylococcus aureus. Lipids 2020;55(2): 101–16.

   Not in our library10.1002/lipd.12213

10. 10.

    Pushparaj Selvadoss P, Nellore J, Balaraman Ravindrran M, Sekar U, Tippabathani J. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa. Artif Cells Nanomed Biotechnol 2018;46(2):268–73.

    Not in our library10.1080/21691401.2017.1307209

11. 11.

    Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009;129 (10):2480–8.

    Not in our library10.1038/jid.2009.93

12. 12.

    Yang H, Chen J, Rathod J, Jiang Y, Tsai P, Hung Y, Lauric acid is an inhibitor of Clostridium difficile growth in vitro and reduces inflammation in a mouse infection model. Front Microbiol 2017;8:2635.

    Not in our library10.3389/fmicb.2017.02635

13. 13.
    Fatty acid extracts from <it>Lucilia sericata </it>larvae promote murine cutaneous wound healing by angiogenic activity · 2010

    Not checked
14. 14.

    Huang W, Tsai T, Chuang L, Li YY, Zouboulis C, Tsai P. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: A comparative study with lauric acid. J Dermatol Sci 2014;73(3):232–40.

    Not in our library10.1016/j.jdermsci.2013.10.010

15. 15.

    Ivanova E, Nguyen S, Guo Y, Baulin V, Webb H, Truong V, Bactericidal activity of self-assembled palmitic and stearic fatty acid crystals on highly ordered pyrolytic graphite. Acta Biomater 2017;59:148–57.

    Not in our library10.1016/j.actbio.2017.07.004

16. 16.

    Nitbani F, Jumina J, Siswanta D, Sholikhah E. Isolation and antibacterial activity test of lauric acid from crude coconut oil (Cocos nucifera L.). Procedia Chem 2016; 18:132–40.

    Not in our library

17. 17.

    Abel-Anzaku A, Akyala J, Adeola J, Ewenighi C. Antibacterial activity of lauric acid on some selected clinical isolates. Ann Clin Lab Res 2017;05:1–5.

    Not in our library

18. 18.

    Nagase S, Matsue M, Mori Y, Honda-Ogawa M, Sugitani K, Sumitomo T, Comparison of the antimicrobial spectrum and mechanisms of organic virgin coconut oil and lauric acid against bacteria. J Wellness Health Care 2017;41(1): 87–95.

    Not in our library

19. 19.

    Yoon B, Jackman J, Kim M, Cho N. Spectrum of membrane morphological responses to antibacterial fatty acids and related surfactants. Langmuir 2015;31 (37):10223–32.

    Not in our library10.1021/acs.langmuir.5b02088

20. 20.

    Kim S, Rhee M. Highly enhanced bactericidal effects of medium chain fatty acids (caprylic, capric, and lauric acid) combined with edible plant essential oils (carvacrol, eugenol, β-resorcylic acid, trans-cinnamaldehyde, thymol, and vanillin) against Escherichia coli O157:H7. Food Control 2016;60:447–54.

    Not in our library

21. 21.

    Cheung Lam A, Sandoval N, Wadhwa R, Gilkes J, Do T, Ernst W, Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic. BMC Res Notes 2016;9:337.

    Not in our library10.1186/s13104-016-2138-8

22. 22.

    Carballeira N, Montano N, Morales C, Mooney J, Torres X, Díaz D, 2-Methoxylated FA display unusual antibacterial activity towards clinical isolates of Methicillin-resistant Staphylococcus aureus (CIMRSA) and Escherichia coli. Lipids 2017;52(6):535–48.

    Not in our library10.1007/s11745-017-4262-1

23. 23.

    Sanabria-Ríos D, Rivera-Torres Y, Rosario J, Gutierrez R, Torres-García Y, Montano N, Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria. Bioorg Med Chem Lett 2015;25(22):5067–71.

    Not in our library10.1016/j.bmcl.2015.10.022

24. 24.
    Prevention of Ophthalmia Neonatorum Caused by <italic toggle="yes">Neisseria gonorrhoeae</italic> Using a Fatty Acid-Based Formulation · 2017

    Not checked
25. 25.

    Fares N, Abu-Harirah H. The sensitivity and specificity of available Helicobacter pylori diagnosis techniques considering the emerging multidrug resistance. Drug Invention Today 2020;12(11):2736–40.

    Not in our library

26. 26.

    Sun M, Zhou Z, Dong J, Zhang J, Xia Y, Shu R. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria. Microb Pathog 2016;99:196–203.

    Not in our library10.1016/j.micpath.2016.08.025

27. 27.

    Sun M, Dong J, Xia Y, Shu R. Antibacterial activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against planktonic and biofilm growing Streptococcus mutans. Microb Pathog 2017;107:212–8.

    Not in our library10.1016/j.micpath.2017.03.040

28. 28.

    Le P, Desbois A. Antibacterial effect of eicosapentaenoic acid against Bacillus cereus and Staphylococcus aureus: Killing kinetics, selection for resistance, and potential cellular target. Mar Drugs 2017;15(11):334.

    Not in our library10.3390/md15110334

29. 29.

    Butt U, ElShaer A, Snyder L, Chaidemenou A, Alany R. Fatty acid microemulsion for the treatment of neonatal conjunctivitis: Quantification, characterisation and evaluation of antimicrobial activity. Drug Deliv Transl Res 2016;6(6):722–34.

    Not in our library10.1007/s13346-016-0338-3

30. 30.
    Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori. · 2015

    Not checked
31. 31.

    Seabra C, Nunes C, Gomez-Lazaro M, Correia M, Machado J, Gonçalves I, Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori. Int J Pharm 2017;519(1–2):128–37.

    Not in our library10.1016/j.ijpharm.2017.01.014

32. 32.

    Habbu P, Warad V, Shastri R, Madagundi S, Kulkarni V. Antimicrobial metabolites from marine microorganisms. Chin J Nat Med 2016;14(2):101–16.

    Not in our library10.1016/s1875-5364(16)60003-1

33. 33.

    Kwan J, Meickle T, Ladwa D, Teplitski M, Paul V, Luesch H. Lyngbyoic acid, a “tagged” fatty acid from a marine cyanobacterium, disrupts quorum sensing in Pseudomonas aeruginosa. Mol Biosyst 2011;7(4):1205–16.

    Not in our library10.1039/c0mb00180e

34. 34.

    Amiri Moghaddam J, Dávila-Céspedes A, Kehraus S, Crüsemann M, Köse M, Müller C, Cyclopropane-containing fatty acids from the marine bacterium Labrenzia sp. 011 with antimicrobial and GPR84 activity. Mar Drugs 2018;16(10): 369.

    Not in our library10.3390/md16100369

35. 35.

    Dasagrandhi C, Ellamar J, Kim Y, Kim H. Antimicrobial activity of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid against methicillin-resistant Staphylococcus aureus. Food Sci Biotechnol 2016;25(6):1671–5.

    Not in our library10.1007/s10068-016-0257-6

36. 36.

    Dasagrandhi C, Kim Y, Kim I, Hou C, Kim H. 7,10-Epoxyoctadeca-7,9-dienoic acid: A small molecule adjuvant that potentiates β-lactam antibiotics against multidrug-resistant Staphylococcus aureus. Indian J Microbiol 2017;57(4):461–9.

    Not in our library10.1007/s12088-017-0680-2

37. 37.

    Sanabria-Ríos D, Rivera-Torres Y, Maldonado-Domínguez G, Domínguez I, Ríos C, Díaz D, Antibacterial activity of 2-alkynoic fatty acids against multidrug-resistant bacteria. Chem Phys Lipids 2014;178:84–91.

    Not in our library10.1016/j.chemphyslip.2013.12.006

38. 38.

    Liu C, Li X, Cheng R, Han Z, Yang L, Song Z, Anti-oral common pathogenic bacterial active acetylenic acids from Thesium chinense Turcz. J Nat Med 2018;72 (2):433–8.

    Not in our library10.1007/s11418-018-1180-3

39. 39.

    Carballeira N New advances in the chemistry of methoxylated lipids. Prog Lipid Res 2002;41(6):437–56.

    Not in our library10.1016/s0163-7827(02)00005-x

40. 40.

    van Eijk E, Wittekoek B, Kuijper E, Smits W. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J Antimicrob Chemother 2017;72(5):1275–84.

    Not in our library10.1093/jac/dkw548

Cited by papers we hold 1

• Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids · 2023
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.